Should You Sell Teladoc Health Stock As Coronavirus Vaccines Succeed?

Should You Sell Teladoc Health Stock As Coronavirus Vaccines Succeed?
Jim Crumly, The Motley Fool

Such a stock is Teladoc Health (NYSE: TDOC). Teladoc is the leader in the space, with a network of over 50,000 clinicians in 450 sub-specialties available to patients in their homes. In fact, some investors may have been distressed about signs that Teladoc's business is hitting a plateau when it reported third-quarter results on Oct. 28.